Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] ...

Takeda (NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less ...

ITP leads to abnormal bruising and bleeding thanks to low platelet levels—a type of blood cell that helps with clotting. A ...

Total testosterone measures the full amount of the hormone in your blood, while free testosterone represents the small, ...

ADMA shares rose 13.8% over three months as demand for Asceniv surged, driving higher 2026 revenues and EBITDA targets amid ...

Yee is joined by two other bullish analysts who are even more optimistic on the stock, earning it a Strong Buy consensus ...

AtkinsRéalis Group Inc. , a world-class engineering services and nuclear company with offices around the world, will hold a ...

Neal Barnard, M.D. is founding president of the Physicians Committee for Responsible Medicine and a respected medical researcher. He has published several books, the latest “Your Body in Balance, The ...

By worrying about perimenopause, are young(ish) women missing a rare “golden window” when they shouldn’t actually have to fixate on their reproductive systems?

Toothio, the leading digital staffing marketplace for dental practices, today launched Mel, the first AI recruiting agent ...

As of Monday, January 05, SAB Biotherapeutics, Inc.’s SABS share price has dipped by 5.57%, which has investors questioning if this is right time to buy.

Existing treatments for other conditions show potential for use in managing type 1 diabetes, a recent scientific conference heard ...